⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL443115 | 1.00 | — | — | |
| SCHEMBL131909 | 1.00 | — | — | |
| SCHEMBL28880988 | 0.97 | USP2 (0.67) | — | |
| Phosphoric Acid SCHEMBL28116580 | 0.91 | USP2 (0.59) | — | |
| SCHEMBL812543 | 0.84 | USP2 (0.86) | — | |
| SCHEMBL7148984 | 0.84 | USP2 (0.86) | — | |
| SCHEMBL25200032 | 0.83 | USP2 (0.52) | — | |
| Glucosaminic Acid SCHEMBL13010965 | 0.82 | USP2 (1.00) | — | |
| Glucosaminic Acid SCHEMBL396940 | 0.82 | USP2 (1.00) | — | |
| Glucosaminic Acid SCHEMBL7642316 | 0.82 | USP2 (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240287143-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Universität Zürich (CH) | 2024-08-29 | — | — | US | claimed |
| EP-3638284-B1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIROMETIX AG (CH) | 2023-08-30 | — | — | EP | claimed |
| US-11680085-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2023-06-20 | — | — | US | claimed |
| EP-3638284-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Virometix AG (CH) | 2020-04-22 | — | — | EP | claimed |
| CN-110891592-A | Cyclic peptides for protection against respiratory syncytial virus | 维罗米蒂克斯股份公司 | 2020-03-17 | — | — | CN | claimed |
| CN-108239664-B | Process for preparing 4-hydroxy-L-threonine | 深圳瑞德林生物技术有限公司 | 2020-01-03 | — | — | CN | claimed |
| WO-2018229156-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIROMETIX AG (CH) | 2018-12-20 | — | — | WO | claimed |
| WO-2012167243-A1 | COMPOSITIONS AND METHODS OF TREATMENT FOR OBESITY | B & P COMPANY, INC. (US) | 2012-12-06 | — | — | WO | claimed |
| EP-0765938-B1 | Fermentative production of vitamin B6 | HOFFMANN LA ROCHE (CH) | 2002-07-03 | — | — | EP | claimed |
| US-6060267-A | EFFICIENT PROCESS BY ADDING 1-DEOXY-D-THREO-PENTULOSE, 4-HYDROXY-L-THREONINE, NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE AND NICOTINAMIDE ADENINE DINUCLEOTIDE TO CELL-FREE SYSTEM AND ACTIVATING ENZYMES | ROCHE VITAMINS, INC. (US) | 2000-05-09 | — | — | US | claimed |
| EP-0950715-A2 | Enzymatic production of vitamin B6 | F. HOFFMANN-LA ROCHE AG (CH) | 1999-10-20 | — | — | EP | claimed |
| US-5766894-A | Production of vitamin B6 by fermentation | ROCHE VITAMINS INC. (US) | 1998-06-16 | — | — | US | claimed |
| EP-0765938-A2 | Fermentative production of vitamin B6 | F. HOFFMANN-LA ROCHE AG (CH) | 1997-04-02 | — | — | EP | claimed |
| JP-9107985-A | — | — | None | — | — | JP | disclosed |
| US-20260137767-A1 | LIPOPEPTIDE BUILDING BLOCKS AND SYNTHETIC VIRUS-LIKE PARTICLES | VIROMETIX AG (CH) | 2026-05-21 | — | — | US | disclosed |
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2026-02-17 | — | — | US | disclosed |
| CN-1153823-A | Fermentative production of vitamin B6 | HOFFMANN LA ROCHE (CH) | 1997-07-09 | — | — | CN | disclosed |
| JP-H09107985-A | PRODUCTION OF VITAMIN B6 | F HOFFMANN LA ROCHE AG | 1997-04-28 | — | — | JP | disclosed |
| EP-0765938-A2 | Fermentative production of vitamin B6 | F. HOFFMANN-LA ROCHE AG (CH) | 1997-04-02 | — | — | EP | disclosed |
| EP-0765938-A2 | Fermentative production of vitamin B6 | F. HOFFMANN-LA ROCHE AG (CH) | 1997-04-02 | — | — | EP | disclosed |